Evidence from mouse tauopathy models and AD neural spheroids has shown that lamivudine can effectively suppress retrotransposon activation, attenuate neuroinflammation (especially TLR and cGAS activation), and preserve neuronal viability (Fig. 1) [100–102]. This evidence concerns the gene CGAS and tauopathy.